Molecular Classification and Therapeutic Targets in Ependymoma

Area of Science:

• Neuro-oncology
• Molecular Pathology

Background:

• Ependymoma tumors exhibit significant biological diversity.
• Molecular classification offers superior characterization of behavior, prognosis, and targeted therapy potential compared to traditional histological grading.

Purpose of the Study:

• To review the current molecular classification of ependymoma.
• To explore the history, histopathology, standard of care, prognosis, oncogenic drivers, and potential molecular targets for all ependymoma subgroups.

Main Methods:

• Comprehensive literature review of ependymoma classification and molecular characteristics.
• Analysis of current understanding of ependymoma oncogenesis and potential therapeutic strategies.

Main Results:

• Identified ten distinct molecular subgroups of ependymoma across spinal, infratentorial, and supratentorial compartments.
• Highlighted varied clinical behaviors and molecular profiles among subgroups.

Conclusions:

• Molecular classification is essential for understanding ependymoma heterogeneity.
• Further research is imperative to identify and develop targeted molecular therapies for all ependymoma subgroups, particularly for unresectable tumors.